helptariff
简体中文
韩国 → 美国HS 300490其他麻醉剂建议委托报关行

药品 › 由混合或非混合产品构成的治病或防病用药品，已配定剂量或制成零售包装

其他麻醉剂

HS 300490韩国 → 美国

目的国关税
0%
普通
联邦增值税（VAT/GST）
无
通关难度
建议委托报关行

1概览

  • 目的国关税: Free (普通, 2 个税号相同) — 与韩国虽有贸易协定，但此税号没有更低的优惠税率，适用基本／最惠国税率。
  • 联邦增值税（VAT/GST）: 无 — 美国没有联邦增值税；各州销售税不在进口环节征收。
  • 该编码涵盖: 其他麻醉剂
  • 额外关税: 至少 +0% — 未找到适用于该原产地与 HS 编码的第99章措施，但这并不保证确实没有。仅适用于该 HS 码的一部分
  • 需留意的制度: 美国小额免税（de minimis）全面中止自 2025-08-29 起，依行政命令 14324，所有国家出口的 800 美元以下货物免税通关已中止。国际邮包与快递小包也须课税，并需办理报关、申报 HS 归类与原产地，小批量寄送难度提高。federalregister.gov

要点

  • 小额免税已无限期暂停：邮递以外方式自 2026-06-24 起，国际邮递自 2026-07-24 起。800 美元免税通关已不存在。
  • 没有联邦增值税；各州销售税或使用税属于进口之后的另一件事，海关不代征。
  • 2,500 美元是简易报关与正式报关的分界。价值 2,500 美元及以下且属 HTSUS 第 1 至 97 章的邮递货物，可适用新设的邮递简易报关程序，关税应于货物抵达次月 7 日前缴纳。
  • 进口商（importer of record）可自行在 ACE 申报，但正式报关须有海关保证金（customs bond），海运货物还须在装船前 24 小时完成进口商安全申报（ISF 10+2）。
  • 第 122 条附加关税已于 2026-07-24 终止，同日起改由覆盖 60 个经济体的第 301 条强迫劳动措施生效。额外关税以第 99 章项目征收，请按报关日核实。

出口方要点

  • 没有出口关税，但仍须办理出口申报。非退税对象且货价在 FOB 200 万韩元以下的，可以清单通关代替出口申报；电子商务等货物在 FOB 500 万韩元以下可采用简易出口申报（《出口及退运通关公告》第 55 条第 1 款第 8 项、第 43 条第 1 款）。
  • 装载期限为出口申报受理之日起 30 日，有正当理由的最长可延长至一年。
  • 出口申报受理证是增值税零税率的凭据，也是申请关税退税的依据（增值税法第 21 条、退税特例法第 14 条）。
  • 出口前应先判定是否为战略物资；属于的须取得产业通商资源部（通过战略物资管理院）的出口许可。
  • 买方在进口国主张优惠税率时需要 FTA 原产地证书：美韩 FTA 为自行签发，中韩 FTA 为机构签发。

数据日期: 2026 HTS Rev.15 · 说明基准日: 2026-09

2归类

HS6 品名

  • ko기타
  • enOther anesthetics
  • zh_hant其他麻醉劑
  • zh_hans其他麻醉剂

美国 税则子目

子目品名
3004.90.10.00Containing antigens or hyaluronic acid or its sodium saltMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other
3004.90.92OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other
3004.90.92.01For veterinary useMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other
3004.90.92.03Containing acyclovir or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.04Containing oseltamivir or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.05Containing valganciclovir, peramivir or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.06OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antivirals
3004.90.92.07Containing fluconazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antifungals
3004.90.92.08OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antifungals
3004.90.92.09Containing metronidazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antiprotozoals (excluding goods described in subheading note 2 to this ch…
3004.90.92.10OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Antiprotozoals (excluding goods described in subheading note 2 to this ch…
3004.90.92.11Containing trimethoprim and sulfamethoxazole or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Sulfonamides
3004.90.92.12OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Sulfonamides
3004.90.92.13Containing levofloxacin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.14Containing linezolid or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.15OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Anti-infective medicaments › Other
3004.90.92.16Containing hydroxyurea or cyclophosphamide or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.17Containing tacrolimus or mycophenolate mofetil or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.18OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Antineoplastic and immunosuppressive medicaments
3004.90.92.19Containing metoprolol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.20Containing amiodarone or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.21Containing diltiazem or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.22Containing hydralazine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.23Containing enoxaparin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.24Containing labetalol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.25Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.26OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Cardiovascular medicaments
3004.90.92.27TolmetinMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.28Tolmetin sodium dihydrateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.29Tolmetin sodium (anhydrous)Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.30For oral suspensionMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.31OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.32For oral suspensionMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.33OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.34Containing O-Acetylsalicylic acid (Aspirin)Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.35Containing tramadolMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.36OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Analgesics, antipyretics and nonhormonal …
3004.90.92.37Containing dexmedetomidine, etomidate, midazolam, propofol or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.38Containing midazolam or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.39Containing phenytoin or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.40Containing propofol or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.41Containing levetiracetam, phenytoin or their saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.42Containing etomidate or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.43OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Anticonvulsants, hypnotics and sedatives
3004.90.92.44Containing lorazepam or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.45Containing olanzapine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.46OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Antidepressants, tranquilizers, and other…
3004.90.92.47Containing rocuronium or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.48Containing succinylcholine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.49OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the central nervous system › Other
3004.90.92.50Containing lidocaine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Dermatological agents and local anesthetics
3004.90.92.51OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Dermatological agents and local anesthetics
3004.90.92.52LaxativesMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.53AntacidsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.54Containing famotidine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.55Containing pantoprazole or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.56Containing ondansetron or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.57Containing glycopyrrolate or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.58Containing loperamide or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.60OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the digestive system
3004.90.92.61Containing furosemide and its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.62Containing hydrochlorothiazide or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.63OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Diuretics
3004.90.92.64Containing calcium gluconateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.65Containing potassium chlorideMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.66Containing sodium bicarbonate, in injection formMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.67OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Preparations primarily affecting the electrolytic, caloric or water balance › Other
3004.90.92.68Cough and cold preparationsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system
3004.90.92.69Containing diphenhydramine or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Antihistamines
3004.90.92.70OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Antihistamines
3004.90.92.71Containing albuterol sulfateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other
3004.90.92.72Containing timolol maleateMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Other
3004.90.92.73OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Medicaments primarily affecting the eyes, ears, or respiratory system › Other › Other
3004.90.92.74Containing heparin sodium or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
3004.90.92.75Containing zoledronic acid or its saltsMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
3004.90.92.76OtherMedicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale › Other › Other › Other › Other
韩国 出口侧编码（参考）
  • 3004901000항결핵제ㆍ구충제ㆍ항암제
  • 3004909100아스피린제제
  • 3004909200항히스타민제제
  • 3004909900기타

美国 案例前三条

不是你的商品？重新搜索

数据日期: 2026 HTS Rev.15

3关税与税费

与韩国虽有贸易协定，但此税号没有更低的优惠税率，适用基本／最惠国税率。

子目品名普通优惠（special）Column 2
3004.90.10.00Containing antigens or hyaluronic acid or its sodium saltFree—Free
3004.90.92OtherFree—30%
3004.90.92.01For veterinary use———
3004.90.92.03Containing acyclovir or its salts———
3004.90.92.04Containing oseltamivir or its salts———
3004.90.92.05Containing valganciclovir, peramivir or their salts———
3004.90.92.06Other———
3004.90.92.07Containing fluconazole or its salts———
3004.90.92.08Other———
3004.90.92.09Containing metronidazole or its salts———
3004.90.92.10Other———
3004.90.92.11Containing trimethoprim and sulfamethoxazole or their salts———
3004.90.92.12Other———
3004.90.92.13Containing levofloxacin or its salts———
3004.90.92.14Containing linezolid or its salts———
3004.90.92.15Other———
3004.90.92.16Containing hydroxyurea or cyclophosphamide or their salts———
3004.90.92.17Containing tacrolimus or mycophenolate mofetil or its salts———
3004.90.92.18Other———
3004.90.92.19Containing metoprolol or its salts———
3004.90.92.20Containing amiodarone or its salts———
3004.90.92.21Containing diltiazem or its salts———
3004.90.92.22Containing hydralazine or its salts———
3004.90.92.23Containing enoxaparin or its salts———
3004.90.92.24Containing labetalol or its salts———
3004.90.92.25Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts———
3004.90.92.26Other———
3004.90.92.27Tolmetin———
3004.90.92.28Tolmetin sodium dihydrate———
3004.90.92.29Tolmetin sodium (anhydrous)———
3004.90.92.30For oral suspension———
3004.90.92.31Other———
3004.90.92.32For oral suspension———
3004.90.92.33Other———
3004.90.92.34Containing O-Acetylsalicylic acid (Aspirin)———
3004.90.92.35Containing tramadol———
3004.90.92.36Other———
3004.90.92.37Containing dexmedetomidine, etomidate, midazolam, propofol or their salts———
3004.90.92.38Containing midazolam or its salts———
3004.90.92.39Containing phenytoin or its salts———
3004.90.92.40Containing propofol or its salts———
3004.90.92.41Containing levetiracetam, phenytoin or their salts———
3004.90.92.42Containing etomidate or its salts———
3004.90.92.43Other———
3004.90.92.44Containing lorazepam or its salts———
3004.90.92.45Containing olanzapine or its salts———
3004.90.92.46Other———
3004.90.92.47Containing rocuronium or its salts———
3004.90.92.48Containing succinylcholine or its salts———
3004.90.92.49Other———
3004.90.92.50Containing lidocaine or its salts———
3004.90.92.51Other———
3004.90.92.52Laxatives———
3004.90.92.53Antacids———
3004.90.92.54Containing famotidine or its salts———
3004.90.92.55Containing pantoprazole or its salts———
3004.90.92.56Containing ondansetron or its salts———
3004.90.92.57Containing glycopyrrolate or its salts———
3004.90.92.58Containing loperamide or its salts———
3004.90.92.60Other———
3004.90.92.61Containing furosemide and its salts———
3004.90.92.62Containing hydrochlorothiazide or its salts———
3004.90.92.63Other———
3004.90.92.64Containing calcium gluconate———
3004.90.92.65Containing potassium chloride———
3004.90.92.66Containing sodium bicarbonate, in injection form———
3004.90.92.67Other———
3004.90.92.68Cough and cold preparations———
3004.90.92.69Containing diphenhydramine or its salts———
3004.90.92.70Other———
3004.90.92.71Containing albuterol sulfate———
3004.90.92.72Containing timolol maleate———
3004.90.92.73Other———
3004.90.92.74Containing heparin sodium or its salts———
3004.90.92.75Containing zoledronic acid or its salts———
3004.90.92.76Other———

第99章额外关税

至少 +0%

输美时加征于上列 HTS 税率之上的各层措施。每一层均标示状态、基准日与出处。

措施加征第9903号税则状态 · 基准日 · 出处
第232条药品该码项下仅部分 8 位号列在范围内（3004.90.10, 3004.90.92），是否征收取决于实际报关号列。部分下属号列 75 项中的 75 项：3004.90.10, 3004.90.92—未计入合计9903.04.60, 9903.04.61, 9903.04.62, 9903.04.63, 9903.04.64, 9903.04.65, 9903.04.66, 9903.04.67, 9903.04.68, 9903.04.69施行中数据日期: 2026-09-15Proclamation 11020, 2 April 2026, 91 FR (2026-06956); CBP CSMS #69395344 (2026-07-30) and #69415934 (2026-08-01)
IEEPA对等关税（已失效）现已不再征收（2026-09-09 基准）。因该日期之前的资料仍在引用，故一并列出。—未计入合计9903.01, 9903.02被判无效相关诉讼进行中数据日期: 2026-09-09Learning Resources, Inc. v. Trump, No. 24-1287 (U.S. 20 Feb 2026)
第122条国际收支附加税（已届期）现已不再征收（2026-07-24 基准）。因该日期之前的资料仍在引用，故一并列出。—未计入合计—已失效相关诉讼进行中数据日期: 2026-07-24Section 122 surcharge: imposed 24 Feb 2026, CIT ruling 7 May 2026, expired 24 July 2026
加征合计至少 +0%

注意事项

  • 合计为下限而非完整估算：第232条药品 无法仅凭 HS 编码量化。
  • 该 HS 码部分在范围内、部分不在（3004.90.10, 3004.90.92），以实际报关的 8 位号列为准。
  • 这些措施以 8 位或 10 位 HTS 税则号列界定。HS6（300490）只能呈现大致情形。
  • US$800 小额免税已暂停，低价包裹同样课税；法律上的废止于 2027-07-01 生效。
  • 关税不是全部：另有 MPF 与（海运时）HMF，本页并未计入。
  • 2026-09-15 基准的信息提供。以报关日施行中的 HTSUS 第99章注释与 CBP CSMS 指引为准 — 请向 CBP 或报关行确认。
小额免税（de minimis）状态

美国 800 美元小额免税

自 2025-08-29 起对所有国家停止适用，并经 2026-06-24 CBP 临时最终规则无限期停止（非邮递立即生效，国际邮件自 2026-07-24）。2026-08-13 国际贸易法院驳回对该停止的诉讼，制度更趋确定。2027-07-01 起依 One Big Beautiful Bill Act 废止；截至 2026-09-09 复查，尚无变更该日期的立法。100 美元礼品与 200 美元随身物品免税仍存续。附有第99章关税的货物不得使用邮递简易报关。

门槛金额:
US$800
暂停适用:
2025-08-29
法律废止:
2027-07-01
CBP interim final rules, 91 FR (2026-12670 / 2026-12669), 24 June 2026

仅供参考，非专业建议。美国附加关税变动频繁且诉讼进行中。实际税额以报关日生效的 HTSUS 第99章注释与 CBP CSMS 公告为准，请向 CBP 或报关行确认。

数据日期: 2026-09-15

  • · 美国没有联邦层级的增值税，海关只征收关税与规费。
  • · 商品处理费（MPF）：正式报关时为申报价格的 0.3464%，上下限每个财政年度按物价重新调整。2026 财政年度（至 2026-09-30）为 33.58 至 651.50 美元；2027 财政年度（自 2026-10-01 起）为 34.58 至 670.86 美元。简易报关改按定额收取，2027 财政年度为 2.77、8.30 或 12.45 美元。
  • · 港口维护费（HMF）：以船舶运抵的货物按价格 0.125% 计收。
  • · 各州销售税或使用税针对货物的后续销售或使用，由各州税务机关管理，与 CBP 无关。
  • · 第 99 章的额外关税加计于一般税率之上。截至 2026-09，包括第 232 条措施与 2026-07-24 生效的第 301 条强迫劳动措施；第 122 条附加关税已于 2026-07-24 终止。请按报关日确认适用情况。

税费概算

采用税率
0%
完税价格
—
关税
—
额外关税（第99章） (≥ 0%)
—
联邦增值税（VAT/GST）
—
预估合计
—

此为概算。实际金额取决于完税价格审定、归类与原产地认定。

数据日期: 2026 HTS Rev.15

4监管要求

  • FD2FDA

    Pharmaceutical products (medicaments, blood, dressings) - FDA-regulated drug/biologic (FD2). Potential/disclaimable flag; submit FDA entry data if FDA-regulated.

    可信度:
    chapter-heuristic
    fda.gov
  • headingDEA

    Medicaments (subset containing controlled substances) - DEA import registration/permit for scheduled-drug content. Substance-dependent, narrow.

    可信度:
    chapter-heuristic
    dea.gov

CBP 未完整公开各 HS 的 PGA 标记，此处以章／品目层级启发式映射。

相关机关

  • 美国海关与边境保护局（CBP）办理进口通关、核定关税与规费，并在口岸执行其他机构的规定cbp.gov
  • 美国国际贸易委员会（USITC）编制并公布 HTSUS，含第 99 章额外关税条款hts.usitc.gov
  • 美国食品药品监督管理局（FDA）食品、药品、医疗器械与化妆品；事先通报与 MoCRA 注册列名fda.gov
  • 美国农业部动植物卫生检验局（APHIS）动植物产品的进口许可与检疫要求aphis.usda.gov
  • 美国联邦通信委员会（FCC）无线电频率设备与设备认证fcc.gov
  • 美国消费品安全委员会（CPSC）消费品与儿童用品认证cpsc.gov

数据日期: 2026-08-27

5单证

韩国 出口单证

  • 出口申报单（수출신고서）
    签发:
    出口商或关税士，在 UNI-PASS 申报
    时点:
    装载前

    填报 HS 编码、数量、金额、贸易条件、原产地与是否申请退税。

    官方页面
  • 出口申报受理证（수출신고필증）
    签发:
    海关
    时点:
    出口申报受理时签发

    用于零税率申报、关税退税、贸易融资与保险。

    官方页面
  • 商业发票
    签发:
    出口商
    时点:
    备齐装运单证时

    进口国海关据以审定完税价格，品名、数量、单价、贸易条件与原产地须准确。

    官方页面
  • 装箱单
    签发:
    出口商
    时点:
    备齐装运单证时

    逐箱内容、重量、体积与唛头。

    官方页面
  • 提单（B/L）或空运单（AWB）
    签发:
    承运人或货运代理
    时点:
    装载后签发

    用于议付或其他付款方式，并供买方提货。

    官方页面
  • FTA 原产地证书
    签发:
    海关、大韩商工会议所（机构签发）或出口商（自行签发）
    时点:
    买方主张优惠前

    美韩 FTA 采自行签发、无固定格式；中韩 FTA 采机构签发；RCEP 按协定所定方式。与台湾地区之间没有协定。

    官方页面
  • 战略物资判定书或出口许可证
    签发:
    战略物资管理院（KOSTI）、产业通商资源部
    时点:
    该项货物出口前

    两用物项须经自行判定或专业判定，必要时取得出口许可。

    官方页面
  • 出口用卫生或检疫证书
    签发:
    食品医药品安全处、农林畜产检疫本部等
    时点:
    进口国要求时

    例如出口食品的卫生证书、植物检疫证书、动物检疫证书。输往中国大陆的食品还须办理海关总署（GACC）境外生产企业注册。

    官方页面
  • 关税退税申请单证
    签发:
    出口商
    时点:
    出口履行后

    按定额退税或个别退税方式，需附进口申报受理证、基础原材料纳税证明等。

    官方页面

美国 进口单证

  • CBP Form 3461（Entry/Immediate Delivery，放行申报表）
    签发:
    美国海关与边境保护局（CBP）
    时点:
    抵达时或抵达前，通过 ACE 电子传输

    放行用文件，一般可在抵达前 5 日内递交。

    官方页面
  • CBP Form 7501（Entry Summary，报关摘要表）
    签发:
    美国海关与边境保护局（CBP）
    时点:
    放行后 10 个工作日内

    载明 HTSUS 归类、完税价格与税额计算，可逐票缴纳或以按月汇总结算方式缴纳。

    官方页面
  • 商业发票
    签发:
    卖方或出口商
    时点:
    随报关单证

    应载明买卖双方、品名、数量、单价与总价、币种、贸易条件与原产地。

    官方页面
  • 装箱单
    签发:
    卖方或出口商
    时点:
    随报关单证

    逐箱内容、重量与唛头，查验时使用。

    官方页面
  • 提单（B/L）或空运单（AWB）
    签发:
    承运人或货运代理
    时点:
    装运时签发

    运输合同与提货权利的凭证。

    官方页面
  • 进口商安全申报（ISF 10+2）
    签发:
    进口商或其代理人
    时点:
    货物装船前至少 24 小时

    仅适用于海运货物，空运、公路与铁路运输不适用。

    官方页面
  • 海关保证金（单票或连续型）
    签发:
    美国财政部认可的担保机构
    时点:
    报关前设立

    正式报关与新设的邮递简易报关程序均须具备。

    官方页面
  • 自由贸易协定原产地声明
    签发:
    出口商、生产商或进口商
    时点:
    主张优惠税率时持有

    韩国原产货物适用美韩 FTA，采自我证明、无固定格式，报关时以特别方案代码 KR 主张。台湾地区与中国大陆同美国之间没有自由贸易协定。

    官方页面
  • 其他主管机构资料（PGA data）
    签发:
    FDA、USDA、FCC、CPSC、EPA 等
    时点:
    随报关单证

    例如食品的 FDA 事先通报（Prior Notice）、依 MoCRA 办理的化妆品工厂注册与产品列名并指定美国责任人、无线电设备的 FCC 符合性声明、儿童用品的 CPSC 证书。

    官方页面

6流程

  1. 装船前申报进口商或代理人在货物装船前至少 24 小时完成进口商安全申报（ISF 10+2），承运人也按同一 24 小时期限传输预报舱单。
  2. 递交报关单证通过 ACE 递交 CBP Form 3461，一般可在抵达前 5 日内申报。抵达后 15 个日历日内未申报的，货物将转入 General Order 仓库。
  3. 审核、查验与机构扣留CBP 可能指定单证审核、X 光或人工查验，FDA、USDA、CPSC 等主管机构也可能另行扣留。
  4. 放行CBP 与各机构的扣留解除后，货物即可放行离开港区。
  5. 报关摘要与缴税放行后 10 个工作日内递交 CBP Form 7501，并缴纳关税、商品处理费与港口维护费，可逐票或按月汇总结算缴纳。
  6. 税额确定（Liquidation）CBP 通常在报关后 314 日内确定税额。事后更正（post-summary correction）与异议（protest）另有期限。
  1. 预报舱单航空公司在抵达前传输预报货物信息。进口商安全申报（ISF）不适用于空运货物。
  2. 递交报关单证通过 ACE 递交 CBP Form 3461，多在航班落地前申报，以便抵达后尽快放行。
  3. 审核与机构扣留CBP 与其他主管机构审核申报，并可能在机场货运站查验。
  4. 放行提货放行后即可从航空货运站提取货物。
  5. 报关摘要与税额确定放行后 10 个工作日内处理 CBP Form 7501 与税款，之后比照海运货物办理税额确定。
  1. 预先传输数据快递企业或邮政机构在货物抵达前将数据传送 CBP。
  2. 报关自 2026-06-24 起，低价值货物不得再凭舱单放行。快件以简易报关（通常为 Entry Type 11）办理，超过 2,500 美元的必须办理正式报关。
  3. 邮递货物自 2026-07-24 起，价值 2,500 美元及以下且可归入 HTSUS 第 1 至 97 章的邮递货物，可适用邮递简易报关程序，由持照报关行或货物所有人、购买人申报，并须具备基本的进口与报关保证金。
  4. 税费计算与缴纳按申报价格计算关税与规费。快递企业通常先行垫付关税再向买方收取；邮递程序下，关税最迟应在包裹抵达次月 7 日前缴纳。
  5. 机构审查与派送食品、化妆品、药品、无线电设备与儿童用品仍须附送主管机构资料。涉及配额、反倾销或反补贴税、第 98 章或第 99 章关税，或主张自由贸易协定优惠的，不得使用邮递简易报关程序。
  1. 入境申报旅客以 CBP Form 6059B 或电子申报方式申报在境外取得的全部物品，并回答入境口岸 CBP 人员的询问。
  2. 个人免税额返美的美国居民一般享有 800 美元个人免税额；非居民随身携带、价值 200 美元及以下的个人与家用物品，依 19 U.S.C. 1321(a)(2)(B) 仍免税。
  3. 商业性货物为转售而携带的货物不适用个人免税额，须与一般进口同样办理简易或正式报关，其他主管机构的规定同样适用。
  4. 缴税超出免税额而申报的物品，其关税在旅客离开海关监管区前于入境口岸缴纳。
显示 韩国 出口侧流程
  1. 事前审视确定 HS 编码并判定是否属战略物资。进口国要求的注册或备案（例如输往中国大陆食品的 GACC 注册、输往美国化妆品的 MoCRA 注册）须在装运前完成。
  2. 出口申报出口商自行或委托关税士在 UNI-PASS 报送出口申报单。拟申请退税的，在申报阶段一并填报相关栏目。
  3. 审核、查验与受理海关审核单证，必要时查验货物，受理申报并签发出口申报受理证。
  4. 进场与装船将集装箱送交堆场或货运站并装船。需跨关区移动时采保税运输。
  5. 装载期限管理应自受理之日起 30 日内完成装载；预计延误的，申请延长装载期限。
  6. 装运单证与后续取得提单办理收款，并办理增值税零税率申报与关税退税申请。

7难度

建议委托报关行

分数: 0.92

这是依公开数据计算的信号，并非咨询意见。

判定理由

  • regime[FDA] FDA drug (+ DEA if controlled)制剂药品；若含管制物质成分，还须办理 DEA 进口登记／许可。fda.gov2026-09-07
  • requirement目的国进口要求 2 件：Medicaments (subset containing controlled substances) - DEA import registration/permit for scheduled-drug content. Substance-dependent, narrow., Pharmaceutical products (medicaments, blood, dressings) - FDA-regulated drug/biologic (FD2). Potential/disclaimable flag; submit FDA entry data if FDA-regulated.dea.gov2026-09-07
  • ambiguity品目归类易生争议 — US 案例 1057 件分散于 103 个下位税号。rulings.cbp.gov2026-09-07
  • timing自 2025-08-29 起，依行政命令 14324，所有国家出口的 800 美元以下货物免税通关已中止。国际邮包与快递小包也须课税，并需办理报关、申报 HS 归类与原产地，小批量寄送难度提高。federalregister.gov2026-09-07

组成

进口要求0.76Medicaments (subset containing controlled substances) - DEA import registration/permit for scheduled-drug content. Substance-dependent, narrow. dea.govPharmaceutical products (medicaments, blood, dressings) - FDA-regulated drug/biologic (FD2). Potential/disclaimable flag; submit FDA entry data if FDA-regulated. fda.govCBP 未提供完整的逐项 HS PGA 标记文件，故采用章／节启发式对应（confidence=chapter-heuristic）。 customs_v0.sqlite:us_requirements
归类模糊度0.80US 归类决定案例 1057 件 · 分散于 103 个下位税号 rulings.cbp.gov美国 CROSS 1057 件中，涉及多个税号者占 21% · 同案一并审视的其他 HS6 共 66 个 rulings.cbp.gov
管制制度1.00FDA drug (+ DEA if controlled) fda.gov
韩国 出口侧备注: 韩国海关长确认规定全属进口端；出口管制（对外贸易法、战略物资等）须另行确认。 unipass.customs.go.kr

数据日期: 2026-09-07

8案例

持有案例:韩国 197 件美国 1057 件台湾 17 件中国 —

先列出目的国核定机关的案例，并按日期由新到旧排序。相似案例本身并不等于同一归类。

美国 案例（目的国）

共 1057 件，显示最新 10 件

再显示 5 件

韩国 案例（出发国）

共 197 件，显示最新 10 件

  • 관세평가분류원ㅇ 재우스오라쿠고에이취플라스타(살리실산); OLAKUKO - H;ㅇ 물품개요 - 살리실산을 주성분으로 한 황색 페이스트를 원형 스펀지 중앙에 채운 후 스트립상의 접착시트에 부착한 것을 소매포장한 것(내용량 : 100g, 12매/box) - 용도: 티눈, 굳은 살, 사마귀 제거(일반의약품)核定编码: 3004909900日期: 2026-02-12文号: CLIP-0072026000156
  • 관세평가분류원Medicaments; 재우스오라쿠고에이취플라스타(살리실산)- 살리실산을 주성분으로 한 황색 페이스트를 원형 스펀지 중앙에 채운 후 스트립상의 접착시트에 부착한 것을 지제상자에 소매포장한 것(내용량 : 100g, 12매/box) - 용도 : 일반의약품(티눈, 굳은 살, 사마귀 제거) ※ 품목분류는 수출입신고 당시의 물품 상태에 따라 변경될 수 있음核定编码: 3004909900日期: 2025-11-11文号: CLIP-0072025004895
  • 관세평가분류원POSSㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...核定编码: 3004909900日期: 2024-03-11文号: CLIP-0072023004368
  • 관세평가분류원S1ㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...核定编码: 3004909900日期: 2024-03-11文号: CLIP-0072023004366
  • 관세평가분류원BOSSㅇ 물품개요 - ① 돼지의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 분말상을 유리용기에 충전한 후 플라스틱제 용기에 블리스터 소포장하여 사용설명서와 함께 종이상자에 소매포장한 것(내용량 : 0.25g) ② 소의 골조직에서 얻은 수산화인회석(Hydroxyapatite)의 백색계 그래뉼상...核定编码: 3004909900日期: 2024-03-11文号: CLIP-0072023004367
再显示 5 件
  • 관세평가분류원Medicaments; DIABEX XR 500mg메트포르민염산염, 미결정셀룰로오스, 스테아르산 마그네슘, 카르복시메틸셀룰로오스나트륨, 히프로멜로오스, 정제수를 혼합하여 조제한 백색 타원형 정제를 수지제 블라스터 포장한 것을 종이제 상자에 소매포장한 것(내용량: 15 x 4ea/60정) - 용도: 경구용 혈당 강하제 ※ 품목분류는 수출입신고 당시의 물품상태에...核定编码: 3004909900日期: 2023-07-14文号: CLIP-0072023002558
  • 관세평가분류원INVISIBLE MASKㅇ 물품개요 - Hydroxypropyl methylcellulose 95%에 레몬향 분말을 혼합·조제한 백색계 분말을 플라스틱 용기에 충전 후 종이상자에 소매포장한 것(내용량 : 800㎎) - 작용 : 비강 내부에 분사하면 내용물이 비강 내의 습기와 결합하여 겔(gel)형태로 변하여 내부를 피복함 - 기능 ...核定编码: 3004909900日期: 2023-03-27文号: CLIP-0072023001085
  • 관세평가분류원Medicaments, packings for retail sale①건조 쑥분말 86%에 물 11%, 칼슘(쑥봉 타는 속도 지연), 옥수수전분(점결제)을 혼합하여 원통형으로 압축 성형 후 건조한 쑥봉에 종이재질의 원통형 지지물(지관)을 결합하고 하단에 접착스티커를 부착시킨 것 180개, ②이면지에 부착된 원형의 피부보호용 스티커(무흔지) 2장, ③제품사용설명서(주요 뜸자리)...核定编码: 3004909900日期: 2021-04-12文号: CLIP-0072021001331
  • 관세평가분류원Medicament; Mentho Pas Lotionㅇ 살리실산메틸, L-멘톨, 리놀린유, 미네랄오일, 소르비탄스테아레이트, 정제수, 카보머941, 트롤아민, 폴리소르베이트60으로 혼합·조제된 백색계 점조액상을 플라스틱 용기에 포장 후 지제박스에 최종 소매포장(내용량 : 100ml)한 것 - 용도 : 의약품(근육통, 요통, 류마티스통증 등 환부에 바름) ※ ...核定编码: 3004909900日期: 2021-04-06文号: CLIP-0072021001328
  • 관세평가분류원Medicaments, anti-cancer preparation TEPADINA, Thiotepaㅇ 주입용액 조제용 티오테파(Thiotepa) 백색 분말을 유리제 용기에 넣어 지제박스에 소매포장한 것(내용량: 15㎎) - 용도 : 항암제(혈액질환, 고형종양 등) ※ 품목분류는 수출입신고 당시의 물품상태에 따라 변경될 수 있음核定编码: 3004901000日期: 2020-04-02文号: CLIP-0072020001282
显示其他国家的案例（15 件）

来源: Federal Register: Indefinite Suspension of the De Minimis Exemption for Merchandise Arriving Through All Modes Other Than the International Postal Network · Federal Register: Indefinite Suspension of the De Minimis Exemption for Mail Shipments and New Postal Informal Entry Process · Federal Register: Notice of Implementation of Executive Order 14324, Suspending Duty-Free De Minimis Treatment for All Countries · CBP Form 7501, Entry Summary (revision 02/26) · CBP: Importer Security Filing (10+2) · Harmonized Tariff Schedule of the United States · Supreme Court of the United States: Learning Resources, Inc. v. Trump (No. 24-1287) · FDA: Registration and Listing of Cosmetic Product Facilities and Products · 联邦公报 — 第 11012 号公告：征收临时进口附加关税（第 122 条，2026-07-24 终止） · 联邦公报 — 第 301 条强迫劳动调查措施（60 个经济体，2026-07-24 生效） · 联邦公报 — 2027 财政年度海关使用者规费物价调整（CBP） · eCFR — 19 CFR 141.5：申报期限（抵达后 15 个日历日） · 韩国关税厅 — 出口通关 · 韩国关税厅 UNI-PASS · 韩国关税厅 FTA 门户 · 韩国战略物资管理院 Yestrade · 韩国国家法令信息中心 — 关税法、对外贸易法 · 韩国农林畜产检疫本部 · 韩国国家法令信息中心 — 出口及退运通关公告（关税厅公告第 2025-73 号） · 韩国法制处 easylaw — 贸易制度Ⅰ（出口）：关税及增值税退还

身份: 货代 — 会改变页面强调的板块